Expression and significance of stem cell markers CK19, Notch3, CD133, P75NTR, STRO-1 and ABCG2 in pulmonary squamous carcinomas

Chinese Journal of Lung Cancer

Volumn 12, Issue 4, 2009, Pages 316-321

  Lin, Xuyong ^a   Liu, Shuli ^a   Liu, Nan ^a   Yang, Xiaoshi ^a   Xu, Hongtao ^a   Wang, Enhua ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Immunohistochemistry; Lung neoplasms; Stem cell marker

Indexed keywords

BREAST CANCER RESISTANCE PROTEIN; CD133 ANTIGEN; CELL MARKER; CK19 PROTEIN; NEUROTROPHIN RECEPTOR P75; NOTCH3 RECEPTOR; STRO 1 PROTEIN; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; CANCER TISSUE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG PARENCHYMA; LUNG SQUAMOUS CELL CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PROTEIN EXPRESSION; SAMPLE; STEM CELL; SURGICAL TECHNIQUE; TISSUE SECTION;

EID: 66749102774     PISSN: 10093419     EISSN: 19996187     Source Type: Journal    
DOI: 10.3779/j.issn.1009-3419.2009.04.11     Document Type: Article

References (15)

1. AI Hajj M, Becker MW, Wicha M, et al. Therapeutic implications of cancer stem cells. Curr Opin Genet Dev, 2004, 14(1): 43-47.
2. Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originate from a primitive hematopoietc cell. Nat Med, 1997, 3(7): 730-737. (Pubitemid 27298715)
3. Collins AT, Berry PA, Hyde C, et al. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res, 2005, 65(23): 10946-10951.
4. O'Brien CA, Pollett A, Gallinger S, et al. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature, 2007, 445(7123): 106-110.
5. Wang J, Guo LP, Chen LZ, et al. Identification of cancer stem cell-like side population cells in human nasopharyngeal carcinoma cell line. Cancer Res, 2007, 67(8): 3716-3724.
6. Kim CF, Jackson EL, Woolfenden AE, et al. Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell, 2005, 121(6): 823-835.
7. Eramo A, Lotti G, Sette G, et al. Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ, 2008, 15(3): 504-515.
8. Ho MM, Ng AV, Lam S, et al. Side population in human lung cancer stem cell lines and tumors is enriched stem-like cancer stem cells. Cancer Res, 2007, 67(10): 4827-4833.
9. Okumura T, Shimada Y, Imamura M, et al. Neurotrophin receptor p75 (NTR) characterizes human esophageal keratinocyte stem cells in vitro. Oncogene, 2003, 22(26): 4017-4026. (Pubitemid 36819642)
10. Chen S, Takahara M, Kido M, et al. Increased expression of an epidermal stem cell marker, cytokeratin 19, in cutaneous squamous cell carcinoma. Br J Dermatol, 2008, 159(4): 952-955.
11. Patrawala L, Calhoun T, Schneider-Broussard R, et al. Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2- cancer cells are similarly tumorigenic. Cancer Res, 2005, 65(14): 6207-6219.
12. Zhang YF, Guo L, Zhao F, et al. Expression and significance of ABCG2 in lung cancer, Med J Chin PLA, 2007, 32(9): 965-967.
13. Wei YP, Wang M, Hua P, et al. Expression of tumor stem sell marker CD133 in non-small cell lung carcinoma and its clinical significance. J SUN Yat-sen Univ (Med Sci), 2008, 29(3): 312-316.
14. Li YZ, Wang FH, Zhao P. Expressions of CD133 and Ki-67 in gastric carcinoma and their clinicopathologic significances. Shijie Huaren Xiaohua Zazhi, 2008, 16(28): 3167-3171.
15. Sergey V, Shmelkov, Jason M. Butler, et al. CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors. J Clin Invest, 2008, 118(6): 2111-2121.